How does ruxolitinib compare with topical calcineurin inhibitors and topical steroids?
Featuring Alexandra Golant, MD |
Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
More from this series
Vitiligo
Why is ruxolitinib uniquely suited to treat vitiligo compared to other JAK inhibitors?
Featuring Neal Bhatia, MD
Vitiligo
How does ruxolitinib compare to topical corticosteroids and topical calcineurin inhibitors for vitiligo?
Featuring Neal Bhatia, MD
Vitiligo
Does the efficacy of ruxolitinib for vitiligo vary across Fitzpatrick skin types?
Featuring Neal Bhatia, MD
Vitiligo
What rate of facial repigmentation was seen in clinical trials for ruxolitinib in patients with vitiligo?
Featuring Neal Bhatia, MD
Related CME
0.75 Credit
Click to save this course
Atopic Dermatitis
CME
WCM25: Path to Relief: Advancing Care in Atopic Dermatitis With JAK Inhibitors: An Online Activity
Release Date
February 27, 2025
0.5 Credit
Click to save this course
Atopic Dermatitis
CME
FC24: Gamechangers in Nonsteroidal Topical Management of Atopic Dermatitis: The Next Generation: An Online Activity
Release Date
December 21, 2024
0.5 Credit
Click to save this course
Atopic Dermatitis
CME
PEDS24: Paving the Way for Non-Steroidal Topicals for Pediatric Patients With Atopic Dermatitis and Plaque Psoriasis: An Online Activity
Release Date
December 19, 2024
Related Media
Powered by Polaris TM
Vitiligo
How does ruxolitinib compare to topical corticosteroids and topical calcineurin inhibitors for vitiligo?Video
Neal D. Bhatia
Linda F. Stein Gold
Atopic Dermatitis
Are there any head-to-head studies that look at the efficacy of topical ruxolitinib cream compared to a topical steroid?Video
Susan C. Taylor
Linda F. Stein Gold